Eighty-two genes were identified as candidate driver genes in tumor samples of 510 LUAD patients (Table 2), including KRAS, TP53, EGFR, STK11, MGA and RB1 which were determined also in tumor samples of 55 LUAD patients (Fig. 3). Here, TP53 is linked to neoplasm.